A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19
Open Access
- 2 April 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 24 (1), 1-3
- https://doi.org/10.1186/s13054-020-2836-4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The Therapeutic Efficacy of Adjunct Therapeutic Plasma Exchange for Septic Shock with Multiple Organ Failure: A Single Center Retrospective ReviewPublished by Research Square Platform LLC ,2020
- Sepsis and septic shock: endothelial molecular pathogenesis associated with vascular microthrombotic diseaseThrombosis Journal, 2019
- Sepsis: The evolution in definition, pathophysiology, and managementSage Open Medicine, 2019
- Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markersCritical Care, 2018
- Endothelial Permeability and Hemostasis in Septic ShockSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2017
- Shock induced endotheliopathy (SHINE) in acute critical illness - a unifying pathophysiologic mechanismCritical Care, 2017
- The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysisCritical Care, 2014
- Use of therapeutic plasma exchange as a rescue therapy in 2009 pH1N1 influenza A—An associated respiratory failure and hemodynamic shockPediatric Critical Care Medicine, 2011
- Bench-to-bedside review: Thrombocytopenia-associated multiple organ failure - a newly appreciated syndrome in the critically illCritical Care, 2006
- Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trialIntensive Care Medicine, 2002